All Articles

With its acquisition of CardinalOps, telemetry giant Cribl isn't just buying tech; it's challenging the security market with an open, AI-native alternative.

A federal judge sanctions top DOJ officials over a 'collusive' $1.8B Trump settlement, exposing a brazen attempt to subvert the law for political gain.

As corporate consolidation and inflation threaten local veterinary clinics, a new consulting firm offers a novel approach: tying its fees to the money it saves them.

With its Q2 earnings call on August 4, Match Group faces a critical test. Can its portfolio adapt to a new era of 'conscious consumption' in dating?

Anythink's new Nature Library isn't just an innovative building; it's a radical bet on ecological connection as the core of community resilience and permanent value.

Despite clear laws, 83% of guide dog users face illegal access denials. A new campaign uses humor to expose a problem with a serious economic cost.

As Meta preps its Q2 2026 results, all eyes are on its dual strategy. Can its AI-powered ad engine fund the costly metaverse vision?

As California's housing crisis deepens, Safehold's modern ground lease model is emerging as a critical tool to unlock stalled affordable housing projects.

As Ribbon Communications prepares its Q2 results, investors watch for proof that its AI and optical growth can overcome market headwinds and project delays.

Markel Canada appoints Marc Copland to scale its property division, leveraging AI and data to tackle complex risks and redefine the competitive landscape.

With backing from surfing icon John John Florence, ex-SpaceX engineers are launching a device to turn seawater into drinking water. Is this the future of hydration?

SunRice is launching a collagen-infused rice, but this isn't just another product. It's a calculated strategic move into the booming U.S. functional food market.

Hirschbach Motor Lines cut its billing cycle from nine days to three. A deep dive into the AI that turns messy paperwork into strategic financial advantage.

A key approval for a single raw material in Japan reveals the new frontier in biopharma: a global race for regulatory compliance that could fast-track cell therapies.

As AT&T plans to end new landline orders in California, a fierce debate erupts over public safety, consumer choice, and the future of essential services.

LumaCina's new CEO isn't a simple replacement. It's a calculated move to pair a strategic architect with a commercial executor to dominate a fragile market.

While California's cannabis market struggles, MWG Holdings posts record growth. We explore their community-first model and data-driven tech defying industry trends.

With Microsoft ending RSAT support, The TestMart's Horizon aims to fill the gap with AI-powered test creation and deterministic, auditable execution.

With a new veteran-led practice, Arango bets its multimodel data platform can unify the fragmented systems that hinder federal agencies and pave the way for AI.

MedStar Washington Hospital Center joins an exclusive club with dual nursing excellence awards, but the real story is how this decade-long journey impacts staff and saves lives.